We invite patients to participate in a programme on new therapies for HIV that are being developed.
In the Pharma-Factory project, scientists are exploring how to modify plant cells to produce new medical products through a process called plant-molecular-farming, or PMF. This includes the development of new antibody molecules for HIV. We invite patients on antiretroviral therapy (treatment/prevention) to contribute views on these potential future medical options and how they are made. Your involvement may include participation in workshops to explore your views and exhibitions of PMF products.
21st November 2019
31st January 2021
The public and patient involvement (PPI) programme of Pharma-Factory is led by St George's, University of London and the London College of Communication (University of the Arts).
The Pharma Factory project is funded by the European Commission H2020 and involves 5 companies, 6 universities and 3 public research institutions across Europe, all focused on development of different medical innovations using PMF.
The project includes a PPI programme to ensure research and the resulting products remain relevant to patients and medical providers and will produce more effective and efficient medical diagnostics and treatments.
Link to project: https://pharmafactory.org
Infectious diseases
London
Identifying and prioritising
Undertaking
Disseminating
Training and support will be provided by members of our research team when required (e.g. to carry out the role of facilitator/ peer interviewer).
£30 and a light meal.
Travel costs will be reimbursed where receipts are provided.
No
Yes
